Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Diabetic Polyneuropathy
NCT01469559Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Aug 2011
- Primary completion
- Jul 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Novolin Toronto insulin in diabetic peripheral neuropathy (DPN), sponsored by University of Calgary. Started Aug 2011; status: completed.
02
Drugs
Novolin Toronto insulin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01469559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469559.